Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

NCT: NCT03527992 · COMPLETED

NCT IDNCT03527992
StatusCOMPLETED
Start Date2018-03-09
Completion2024-10-03
SponsorUniversity Hospital, Toulouse (OTHER)
First posted
Last updated

Brief Summary

Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.

Frequently Asked Questions

What is Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia?

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia is a clinical trial registered under NCT03527992. Current status: COMPLETED.

What is the status of NCT03527992?

The current status of NCT03527992 (Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia) is: COMPLETED.

When did Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia start?

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia started on 2018-03-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.